{"lang": "en", "created_at": "2021-01-11T21:25:35.000Z", "text": "#ASH20: As usual, the Adelaide Group has presented a fascinating set of results of the adverse prognosis of having additional cancer mutated genes in chronic myeloid leukemia treated with Imatinib in progression free survival, molecular response, and impending mutations. https://t.co/yVW7OH6fJ0", "id": "1348742877795536900", "diputado": {"apellidos": "Steegmann Olmedillas", "formacion": "Vox", "apellidosNombre": "Steegmann Olmedillas, Juan Luis", "fchBaja": "", "genero": 1, "fchAlta": "22/11/2019", "idLegislatura": 14, "grupo": "Grupo Parlamentario VOX", "idCircunscripcion": 28, "nombreCircunscripcion": "Madrid", "nombre": "Juan Luis", "codParlamentario": 135, "twitter": "https://twitter.com/jlsteeg_doc", "twitterUserName": "jlsteeg_doc", "twitterUserId": "900446435111579648"}}